DOI:
10.1055/s-00000005
Aktuelle Rheumatologie
Issue S 1 ·
Volume 8 ·
April 1983
DOI: 10.1055/s-002-9982
eFirst
Issue
Most Read
1
Zeidler, H.:
Present State of the Art and Critical Assessment of Treatment with Auranofin, Parenteral Gold and D-Penicillamin
5
Tausch, G.;
Teherani, D. K.;
Altmann, H.;
Bröll, H.;
Eberl, R.;
Topaloglou, A.:
Concentration of Gold in Blood (Total), Erythrocytes and Chromatin of Lymphocytes after Therapy with Auro-Thiomalat and Triethylphosphin-Gold in Patients with Rheumatoid Arthritis
9
Menninger, H.;
Burkhardt, H.:
Pharmacological Queries by a Clinician in respect of Auranofin
14
Schröder, O.;
Herrlinger, J. D.:
Different Dosage Schedules during the First Weeks of Gold Treatment of Patients Suffering from Rheumatoid Arthritis
17
Graudal, H.:
Course of Rheumatoid Arthritis during Long-Term Chrysotherapy at Low Dosage Levels
19
Rau, R.;
Herborn, G.:
Comparison of Efficacy and Tolerance of NA-Aurothiomalate (Tauredon®) and Aurothioglucose (Aureotan®)
25
Ewald, R. W.;
Mayer, M.;
Römer, W.:
HL-A Antigens and Gold-Induced Side Effects in Patients with Rheumatoid Arthritis
28
Mattern, H.;
Evers, W.;
Werner, M.;
Fricke, G.:
Chrysotherapy or D-Penicillamine in the Treatment of Rheumatoid Arthritis?
32
Kaiser, H.;
Fehr, W.:
Investigations on Compliance with Chrysotherapy
36
Bandilla, K.;
Baumgarten, F.;
Missler, B.:
Clinical Experience with Long-Term Therapy of Rheumatoid Arthritis with Oral Gold (Auranofin)
40
Müller-Faßbender, H.;
Kaik, D.;
Rau, R.;
Schattenkirchner, M.;
Zeidler, H.:
Controlled Double-Blind Comparative Study of Auranofin and Aurothiomalat
44
Schattenkirchner, M.;
Krüger, K.:
The Federal German Drug Safety Programme- Ridaura®
